Leaflet KETAMINA PANPHARMA 50mg / ml solution for injection


Indicated for: general anesthesia; procedural sedation

Route of administration: injectable

Substance: ketamine (general anesthetic)

ATC: N01AX03 (Nervous system | Anesthetics, general | Other general anesthetics)

Ketamine is a medication primarily used as a general anesthetic, with analgesic and sedative properties. It is commonly used in surgical and medical procedures, especially in emergency situations, due to its rapid onset and safety in maintaining respiratory and cardiovascular functions.

In lower doses, ketamine is used to treat acute and chronic pain, and it has recently been approved for treatment-resistant depression in the form of a nasal spray (esketamine). It works by blocking NMDA receptors in the brain, which affects pain perception and mood regulation.

Side effects may include hallucinations, confusion, dizziness, increased blood pressure, or a rapid heart rate. Recreationally, ketamine is abused for its dissociative effects, which can lead to addiction and health issues. Its administration must be strictly supervised by qualified medical personnel.

General data about KETAMINA PANPHARMA 50mg / ml

  • Substance: ketamine
  • Date of last drug list: 01-10-2024
  • Commercial code: W03854001
  • Concentration: 50mg / ml
  • Pharmaceutical form: solution for injection
  • Packing volume: 5 ml
  • Product type: generic
  • Prescription restrictions: TAB2 - Medicines that are issued with a special prescription (narcotics) in yellow color.

Marketing authorisation

  • Manufacturer: ROTEXMEDICA GMBH ARZNEIMITTEL WERK - GERMANIA
  • Holder: PANPHARMA - FRANTA
  • Number: 9130/2016/01
  • Shelf life: 2 years

Concentrations available for ketamine

  • 50mg/10ml
  • 50mg/ml